Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1996 Oct 1;93(20):10966–10971. doi: 10.1073/pnas.93.20.10966

An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis.

J S Anderson 1, M Teutsch 1, Z Dong 1, H H Wortis 1
PMCID: PMC38267  PMID: 8855292

Abstract

Mutations of the Bruton's tyrosine kinase (btk) gene cause X-linked agammaglobulinemia (XLA) in humans and X-linked immune deficiency (Xid) in mice. To establish the BTK role in B-cell activation we examined the responses of wild-type and Xid B cells to stimulation through surface IgM and CD40, the transducers of thymus independent-type 2 and thymus-dependent activation, respectively. Wild-type BTK was necessary for proliferation induced by soluble anti-IgM (a prototype for thymus independent-type 2 antigen), but not for responses to soluble CD40 ligand (CD40L, the B-cell activating ligand expressed on T-helper cells). In the absence of wild-type BTK, B cells underwent apoptotic death after stimulation with anti-IgM. In the presence of wild-type but not mutated BTK, anti-IgM stimulation reduced apoptotic cell death. In contrast, CD40L increased viability of both wild-type and Xid B cells. Importantly, viability after stimulation correlated with the induced expression of bcl-XL. In fresh ex vivo small resting B cells from wild-type mice there was only barely detectable bcl-XL protein, but there was more in the larger, low-density ("activated") splenic B cells and peritoneal B cells. In vitro Bcl-XL induction following ligation of sIgM-required BTK, was cyclosporin A (CsA)-sensitive and dependent on extracellular Ca2+. CD40-mediated induction of bcl-x required neither wild-type BTK nor extracellular Ca2+ and was insensitive to CsA. These results indicate that BTK lies upstream of bcl-XL in the sIgM but not the CD40 activation pathway. bcl-XL is the first induced protein to be placed downstream of BTK.

Full text

PDF
10971

Images in this article

10970Fig. 4
on p.10970

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allman D. M., Ferguson S. E., Lentz V. M., Cancro M. P. Peripheral B cell maturation. II. Heat-stable antigen(hi) splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. J Immunol. 1993 Nov 1;151(9):4431–4444. [PubMed] [Google Scholar]
  2. Aoki Y., Isselbacher K. J., Pillai S. Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells. Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10606–10609. doi: 10.1073/pnas.91.22.10606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Armitage R. J., Fanslow W. C., Strockbine L., Sato T. A., Clifford K. N., Macduff B. M., Anderson D. M., Gimpel S. D., Davis-Smith T., Maliszewski C. R. Molecular and biological characterization of a murine ligand for CD40. Nature. 1992 May 7;357(6373):80–82. doi: 10.1038/357080a0. [DOI] [PubMed] [Google Scholar]
  4. Boise L. H., González-García M., Postema C. E., Ding L., Lindsten T., Turka L. A., Mao X., Nuñez G., Thompson C. B. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 1993 Aug 27;74(4):597–608. doi: 10.1016/0092-8674(93)90508-n. [DOI] [PubMed] [Google Scholar]
  5. Boise L. H., Minn A. J., Noel P. J., June C. H., Accavitti M. A., Lindsten T., Thompson C. B. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity. 1995 Jul;3(1):87–98. doi: 10.1016/1074-7613(95)90161-2. [DOI] [PubMed] [Google Scholar]
  6. Bolen J. B. Protein tyrosine kinases in the initiation of antigen receptor signaling. Curr Opin Immunol. 1995 Jun;7(3):306–311. doi: 10.1016/0952-7915(95)80103-0. [DOI] [PubMed] [Google Scholar]
  7. Campana D., Farrant J., Inamdar N., Webster A. D., Janossy G. Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. J Immunol. 1990 Sep 15;145(6):1675–1680. [PubMed] [Google Scholar]
  8. Choi M. S., Holmann M., Atkins C. J., Klaus G. G. Expression of bcl-x during mouse B cell differentiation and following activation by various stimuli. Eur J Immunol. 1996 Mar;26(3):676–682. doi: 10.1002/eji.1830260325. [DOI] [PubMed] [Google Scholar]
  9. Chung J., Kuo C. J., Crabtree G. R., Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell. 1992 Jun 26;69(7):1227–1236. doi: 10.1016/0092-8674(92)90643-q. [DOI] [PubMed] [Google Scholar]
  10. Defranco A. L., Raveche E. S., Asofsky R., Paul W. E. Frequency of B lymphocytes responsive to anti-immunoglobulin. J Exp Med. 1982 May 1;155(5):1523–1536. doi: 10.1084/jem.155.5.1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Grillot D. A., Merino R., Pena J. C., Fanslow W. C., Finkelman F. D., Thompson C. B., Nunez G. bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J Exp Med. 1996 Feb 1;183(2):381–391. doi: 10.1084/jem.183.2.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hasbold J., Klaus G. G. B cells from CBA/N mice do not proliferate following ligation of CD40. Eur J Immunol. 1994 Jan;24(1):152–157. doi: 10.1002/eji.1830240123. [DOI] [PubMed] [Google Scholar]
  13. Hawrylowicz C. M., Keeler K. D., Klaus G. G. Activation and proliferation signals in mouse B cells. I. A comparison of the capacity of anti-Ig antibodies or phorbol myristic acetate to activate B cells from CBA/N or normal mice into G1. Eur J Immunol. 1984 Mar;14(3):244–250. doi: 10.1002/eji.1830140308. [DOI] [PubMed] [Google Scholar]
  14. Howard M., Pesavento P., Stein P. LPS-activated CBA/N mouse B cells respond to anti-Ig and a BSF-1-like factor. J Immunol. 1986 Jun 15;136(12):4531–4537. [PubMed] [Google Scholar]
  15. Illera V. A., Perandones C. E., Stunz L. L., Mower D. A., Jr, Ashman R. F. Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. J Immunol. 1993 Sep 15;151(6):2965–2973. [PubMed] [Google Scholar]
  16. Ishida T., Kobayashi N., Tojo T., Ishida S., Yamamoto T., Inoue J. CD40 signaling-mediated induction of Bcl-XL, Cdk4, and Cdk6. Implication of their cooperation in selective B cell growth. J Immunol. 1995 Dec 15;155(12):5527–5535. [PubMed] [Google Scholar]
  17. Kerner J. D., Appleby M. W., Mohr R. N., Chien S., Rawlings D. J., Maliszewski C. R., Witte O. N., Perlmutter R. M. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity. 1995 Sep;3(3):301–312. doi: 10.1016/1074-7613(95)90115-9. [DOI] [PubMed] [Google Scholar]
  18. Khan W. N., Alt F. W., Gerstein R. M., Malynn B. A., Larsson I., Rathbun G., Davidson L., Müller S., Kantor A. B., Herzenberg L. A. Defective B cell development and function in Btk-deficient mice. Immunity. 1995 Sep;3(3):283–299. doi: 10.1016/1074-7613(95)90114-0. [DOI] [PubMed] [Google Scholar]
  19. Kuo C. J., Chung J., Fiorentino D. F., Flanagan W. M., Blenis J., Crabtree G. R. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature. 1992 Jul 2;358(6381):70–73. doi: 10.1038/358070a0. [DOI] [PubMed] [Google Scholar]
  20. Mond J. J., Scher I., Cossman J., Kessler S., Mongini P. K., Hansen C., Finkelman F. D., Paul W. E. Role of the thymus in directing the development of a subset of B lymphocytes. J Exp Med. 1982 Mar 1;155(3):924–936. doi: 10.1084/jem.155.3.924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Motoyama N., Wang F., Roth K. A., Sawa H., Nakayama K., Nakayama K., Negishi I., Senju S., Zhang Q., Fujii S. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science. 1995 Mar 10;267(5203):1506–1510. doi: 10.1126/science.7878471. [DOI] [PubMed] [Google Scholar]
  22. Norvell A., Mandik L., Monroe J. G. Engagement of the antigen-receptor on immature murine B lymphocytes results in death by apoptosis. J Immunol. 1995 May 1;154(9):4404–4413. [PubMed] [Google Scholar]
  23. Núez G., Merino R., Grillot D., González-García M. Bcl-2 and Bcl-x: regulatory switches for lymphoid death and survival. Immunol Today. 1994 Dec;15(12):582–588. doi: 10.1016/0167-5699(94)90221-6. [DOI] [PubMed] [Google Scholar]
  24. Ohta K., Iwai K., Kasahara Y., Taniguchi N., Krajewski S., Reed J. C., Miyawaki T. Immunoblot analysis of cellular expression of Bcl-2 family proteins, Bcl-2, Bax, Bcl-X and Mcl-1, in human peripheral blood and lymphoid tissues. Int Immunol. 1995 Nov;7(11):1817–1825. doi: 10.1093/intimm/7.11.1817. [DOI] [PubMed] [Google Scholar]
  25. Parker D. C., Wadsworth D. C., Schneider G. B. Activation of murine B lymphocytes by anti-immunoglobulin is an inductive signal leading to immunoglobulin secretion. J Exp Med. 1980 Jul 1;152(1):138–150. doi: 10.1084/jem.152.1.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Price D. J., Grove J. R., Calvo V., Avruch J., Bierer B. E. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science. 1992 Aug 14;257(5072):973–977. doi: 10.1126/science.1380182. [DOI] [PubMed] [Google Scholar]
  27. Rawlings D. J., Saffran D. C., Tsukada S., Largaespada D. A., Grimaldi J. C., Cohen L., Mohr R. N., Bazan J. F., Howard M., Copeland N. G. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science. 1993 Jul 16;261(5119):358–361. doi: 10.1126/science.8332901. [DOI] [PubMed] [Google Scholar]
  28. Santos-Argumedo L., Lund F. E., Heath A. W., Solvason N., Wu W. W., Grimaldi J. C., Parkhouse R. M., Howard M. CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction. Int Immunol. 1995 Feb;7(2):163–170. doi: 10.1093/intimm/7.2.163. [DOI] [PubMed] [Google Scholar]
  29. Saouaf S. J., Mahajan S., Rowley R. B., Kut S. A., Fargnoli J., Burkhardt A. L., Tsukada S., Witte O. N., Bolen J. B. Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9524–9528. doi: 10.1073/pnas.91.20.9524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Scheuermann R. H., Racila E., Tucker T., Yefenof E., Street N. E., Vitetta E. S., Picker L. J., Uhr J. W. Lyn tyrosine kinase signals cell cycle arrest but not apoptosis in B-lineage lymphoma cells. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4048–4052. doi: 10.1073/pnas.91.9.4048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sentman C. L., Shutter J. R., Hockenbery D., Kanagawa O., Korsmeyer S. J. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell. 1991 Nov 29;67(5):879–888. doi: 10.1016/0092-8674(91)90361-2. [DOI] [PubMed] [Google Scholar]
  32. Takata M., Kurosaki T. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2. J Exp Med. 1996 Jul 1;184(1):31–40. doi: 10.1084/jem.184.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tarakhovsky A., Turner M., Schaal S., Mee P. J., Duddy L. P., Rajewsky K., Tybulewicz V. L. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature. 1995 Mar 30;374(6521):467–470. doi: 10.1038/374467a0. [DOI] [PubMed] [Google Scholar]
  34. Thomas J. D., Sideras P., Smith C. I., Vorechovský I., Chapman V., Paul W. E. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science. 1993 Jul 16;261(5119):355–358. doi: 10.1126/science.8332900. [DOI] [PubMed] [Google Scholar]
  35. Tsien R. Y. New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structures. Biochemistry. 1980 May 27;19(11):2396–2404. doi: 10.1021/bi00552a018. [DOI] [PubMed] [Google Scholar]
  36. Tsukada S., Rawlings D. J., Witte O. N. Role of Bruton's tyrosine kinase in immunodeficiency. Curr Opin Immunol. 1994 Aug;6(4):623–630. doi: 10.1016/0952-7915(94)90151-1. [DOI] [PubMed] [Google Scholar]
  37. Tsukada S., Saffran D. C., Rawlings D. J., Parolini O., Allen R. C., Klisak I., Sparkes R. S., Kubagawa H., Mohandas T., Quan S. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell. 1993 Jan 29;72(2):279–290. doi: 10.1016/0092-8674(93)90667-f. [DOI] [PubMed] [Google Scholar]
  38. Vetrie D., Vorechovský I., Sideras P., Holland J., Davies A., Flinter F., Hammarström L., Kinnon C., Levinsky R., Bobrow M. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature. 1993 Jan 21;361(6409):226–233. doi: 10.1038/361226a0. [DOI] [PubMed] [Google Scholar]
  39. Wechsler R. J., Monroe J. G. Immature B lymphocytes are deficient in expression of the src-family kinases p59fyn and p55fgr1. J Immunol. 1995 Feb 15;154(4):1919–1929. [PubMed] [Google Scholar]
  40. Woodland R. T., Schmidt M. R., Korsmeyer S. J., Gravel K. A. Regulation of B cell survival in xid mice by the proto-oncogene bcl-2. J Immunol. 1996 Mar 15;156(6):2143–2154. [PubMed] [Google Scholar]
  41. Woodland R. T., Schmidt M. R., Riggs J. E., Korsmeyer S. J., Lussier A. M., Gravel K. A. Radiation-induced apoptosis is differentially regulated in primary B cells from normal mice and mice with the CBA/N X-linked immunodeficiency. J Immunol. 1995 Oct 1;155(7):3453–3463. [PubMed] [Google Scholar]
  42. Wortis H. H., Burkly L., Hughes D., Roschelle S., Waneck G. Lack of mature B cells in nude mice with X-linked immune deficiency. J Exp Med. 1982 Mar 1;155(3):903–913. doi: 10.1084/jem.155.3.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Wortis H. H., Teutsch M., Higer M., Zheng J., Parker D. C. B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3348–3352. doi: 10.1073/pnas.92.8.3348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Zhang R., Alt F. W., Davidson L., Orkin S. H., Swat W. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature. 1995 Mar 30;374(6521):470–473. doi: 10.1038/374470a0. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES